• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定腹膜透析患者死亡的风险因素。

Risk factors for mortality in stable peritoneal dialysis patients.

机构信息

Division of Nephrology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea.

出版信息

Ren Fail. 2012;34(2):149-54. doi: 10.3109/0886022X.2011.646808. Epub 2012 Jan 20.

DOI:10.3109/0886022X.2011.646808
PMID:22260239
Abstract

BACKGROUND

The mortality rates of end-stage renal disease patients have significantly declined over the past decade. However, there are few reports on the risk factors for mortality in stable peritoneal dialysis (PD) patients who survive for a considerable time.

PATIENTS AND METHODS

We reviewed the medical records and identified all adult patients who received PD between April 2001 and March 2009 in our institution. The total cohort was 550 patients. Among these patients, 383 patients were enrolled as stable PD patients.

RESULTS

The cumulative survival of the stable PD patients was 91.6% at 3 years and 78.7% at 5 years. On univariate analysis, old age (≥65 years of age), hypoalbuminemia (<35 g/L), log C-reactive protein (CRP) (≥0.84), phosphorus (<1.13 mmol/L), statin, icodextrin, and the Davies index were associated with mortality for all PD patients. Old age, hypoalbuminemia, log CRP, phosphorus, the residual renal function (RRF) (≤4 mL/min/1.73 m2) at 24 months, renin-angiotensin system blockade, icodextrin, and the Davies index were associated with mortality for the stable PD patients. Multivariate analysis showed that, among the variables, age, log CRP, phosphorus, initial RRF, and the Davies index were associated with mortality for all PD patients. In stable PD patients, age, log CRP, phosphorus, RRF at 24 months, and the Davies index were associated with mortality.

CONCLUSION

Initial high RRF combined with the RRF preservation, maintenance of proper phosphorus, control of inflammation, and proper management of comorbidities may help to improve the survival of PD patients including stable PD patients.

摘要

背景

在过去的十年中,终末期肾病患者的死亡率显著下降。然而,对于存活时间较长的稳定腹膜透析(PD)患者,关于其死亡风险因素的报道很少。

患者和方法

我们回顾了病历,确定了 2001 年 4 月至 2009 年 3 月在我院接受 PD 的所有成年患者。总队列为 550 例患者。在这些患者中,383 例被纳入稳定 PD 患者。

结果

稳定 PD 患者的累积生存率为 3 年时为 91.6%,5 年时为 78.7%。单因素分析显示,高龄(≥65 岁)、低白蛋白血症(<35 g/L)、C 反应蛋白(CRP)对数(≥0.84)、磷(<1.13 mmol/L)、他汀类药物、艾考糊精和 Davies 指数与所有 PD 患者的死亡率相关。高龄、低白蛋白血症、CRP 对数、磷、24 个月时的残余肾功能(RRF)(≤4 mL/min/1.73 m2)、肾素-血管紧张素系统阻滞剂、艾考糊精和 Davies 指数与稳定 PD 患者的死亡率相关。多因素分析显示,在这些变量中,年龄、CRP 对数、磷、初始 RRF 和 Davies 指数与所有 PD 患者的死亡率相关。在稳定 PD 患者中,年龄、CRP 对数、磷、24 个月时的 RRF 和 Davies 指数与死亡率相关。

结论

初始高 RRF 结合 RRF 维持、适当的磷水平、控制炎症和适当的合并症管理,可能有助于提高 PD 患者的生存率,包括稳定 PD 患者。

相似文献

1
Risk factors for mortality in stable peritoneal dialysis patients.稳定腹膜透析患者死亡的风险因素。
Ren Fail. 2012;34(2):149-54. doi: 10.3109/0886022X.2011.646808. Epub 2012 Jan 20.
2
Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.炎症、残余肾功能和心脏肥大相互关联,并产生不利的综合作用,增加腹膜透析患者的死亡率和心血管死亡风险。
J Am Soc Nephrol. 2004 Aug;15(8):2186-94. doi: 10.1097/01.ASN.0000135053.98172.D6.
3
Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.长期腹膜透析患者残余肾功能的下降速率与全因死亡率及技术失败相关。
Nephrol Dial Transplant. 2009 Sep;24(9):2909-14. doi: 10.1093/ndt/gfp056. Epub 2009 Feb 18.
4
Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.腹膜透析患者生存率:瑞典与韩国中心的比较
Nephrol Dial Transplant. 2005 Jun;20(6):1207-13. doi: 10.1093/ndt/gfh772. Epub 2005 Mar 22.
5
Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?有和无残余肾功能的中国腹膜透析患者的高磷血症:有哪些影响?
Am J Kidney Dis. 2004 Apr;43(4):712-20.
6
Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.腹膜透析患者腹膜转运率及透析充分性与炎症的关系。
Adv Perit Dial. 2006;22:2-6.
7
Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.腹膜透析中残余肾功能、炎症与贫血之间的关系。
Adv Perit Dial. 2007;23:140-3.
8
Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.对不同程度残余肾功能的腹膜透析患者预后预测因素的重要区分。
Nephrol Dial Transplant. 2005 Feb;20(2):396-403. doi: 10.1093/ndt/gfh331. Epub 2004 Jun 8.
9
Effectiveness of furosemide in patients on peritoneal dialysis.速尿对腹膜透析患者的疗效。
CANNT J. 2006 Jul-Sep;16(3):40-4.
10
Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial.低蛋白饮食加用酮酸治疗的腹膜透析患者残余肾功能的更好保留:一项前瞻性随机试验。
Nephrol Dial Transplant. 2009 Aug;24(8):2551-8. doi: 10.1093/ndt/gfp085. Epub 2009 Mar 3.

引用本文的文献

1
Assessing biomarker trajectories for mortality risk in peritoneal dialysis: A focus on multivariate joint modeling.评估腹膜透析患者死亡风险的生物标志物轨迹:聚焦多变量联合建模。
PLoS One. 2025 Jul 28;20(7):e0320385. doi: 10.1371/journal.pone.0320385. eCollection 2025.
2
Longer serum phosphorus time in range associated with lower mortality risk among peritoneal dialysis patients: a multicenter retrospective cohort study.血清磷时间在范围内与腹膜透析患者的死亡风险降低相关:一项多中心回顾性队列研究。
BMC Nephrol. 2024 Mar 29;25(1):117. doi: 10.1186/s12882-023-03395-9.
3
The significance of follow-up serum uric acid levels in predicting all-cause mortality and cardiovascular mortality in peritoneal dialysis patients.
随访血清尿酸水平对预测腹膜透析患者全因死亡率和心血管死亡率的意义。
Ther Apher Dial. 2023 Feb;27(1):83-90. doi: 10.1111/1744-9987.13892. Epub 2022 Jun 29.
4
Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis.炎症相关预后评分对持续不卧床腹膜透析患者预后的预测价值。
BMC Nephrol. 2018 Oct 26;19(1):297. doi: 10.1186/s12882-018-1092-1.
5
Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients.起始腹膜透析患者的早逝和晚逝的患者特征和风险因素。
Sci Rep. 2016 Aug 31;6:32359. doi: 10.1038/srep32359.
6
Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients - Independently of Cardiac Failure.水负荷过重是腹膜透析患者死亡率的强预测因素——独立于心力衰竭。
PLoS One. 2016 Jul 14;11(7):e0158741. doi: 10.1371/journal.pone.0158741. eCollection 2016.
7
Fat tissue and inflammation in patients undergoing peritoneal dialysis.接受腹膜透析患者的脂肪组织与炎症
Clin Kidney J. 2016 Jun;9(3):374-80. doi: 10.1093/ckj/sfw007. Epub 2016 Mar 24.
8
Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study.老年腹膜透析与老年血液透析患者及年轻腹膜透析患者的比较:一项韩国前瞻性队列研究的竞争风险分析
PLoS One. 2015 Jun 29;10(6):e0131393. doi: 10.1371/journal.pone.0131393. eCollection 2015.
9
A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics.一项关于托伐普坦对糖尿病患者腹膜透析残余肾功能影响的初步研究。
Perit Dial Int. 2015 Sep-Oct;35(5):552-8. doi: 10.3747/pdi.2013.00290. Epub 2014 Jul 31.
10
High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.高敏 C 反应蛋白预测腹膜透析患者的死亡率和技术失败。
PLoS One. 2014 Mar 25;9(3):e93063. doi: 10.1371/journal.pone.0093063. eCollection 2014.